Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Jan. 01, 2022 |
Jan. 02, 2021 |
|
| Summary Of Significant Accounting Policies [Line Items] | |||
| Right-of-use assets | $ 19.2 | $ 22.8 | |
| Retained earnings | 450.0 | 363.3 | |
| Long-lived asset impairment | 0.0 | ||
| Contract asset, current | 3.8 | 2.2 | |
| Contract Liabilities, current | 3.3 | 4.4 | |
| Research and development costs charged to expense | $ 17.4 | $ 16.8 | $ 15.6 |
| Custom Products [Member] | Minimum [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Contract period for sale of product | 3 months | ||
| Custom Products [Member] | Maximum [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Contract period for sale of product | 1 year | ||
| X | ||||||||||
- Definition Contract period for sale of product. No definition available.
|
| X | ||||||||||
- Definition Summary of significant accounting policies. No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of lessee's right to use underlying asset under operating lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|